Botanical Genetics, LLC
Botanical Genetics focuses on cannabis biotechnology, our mission is: To develop proprietary cannabis strains for important new medicines and agricultural crops. Our partnership with the leading Canadian cannabis research company, Anandia Labs, Inc. and collaborations with major U.S. universities enable Botanical Genetics to legally conduct a full spectrum of cannabis research. Because of our exclusive cannabinoid biosynthesis licenses, Botanical Genetics possesses a substantial competitive advantage in the development of medical marijuana and industrial hemp.
Our Parent Company
Botanical Genetics is a wholly-owned subsidiary of 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company focused on technology which allows for the increase or decrease in the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company’s primary mission is to reduce the harm caused by smoking. 22nd Century has an extensive intellectual property portfolio of issued patents and patent applications relating to the tobacco and cannabis plants. Visit xxiicentury.com for more information.
The laboratories of Botanical Genetics and 22nd Century are located on the Buffalo Niagara Medical Campus at 73 High Street, Buffalo, New York 14203. Our laboratories provide the Company with the in-house capability to develop important new enabling technologies and gene discovery in both tobacco and cannabis that could revolutionize both the medical marijuana and smoking cessation markets.